[Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
The analysis of the mode of action of lipid-lowering drugs requires a better understanding of the lipoprotein and cholesterol metabolism processes. The strides observed during the last years in this field are conditioning the development of pharmacologic and therapeutic researches. Moreover the use of new experimental models contributes to this progress by multiplying the study ways.
D000818:Animals; D001053:Apolipoproteins / Q000378:metabolism; D001161:Arteriosclerosis / Q000378:metabolism; D002784:Cholesterol / Q000097:blood / Q000378:metabolism*; D002914:Chylomicrons / Q000378:metabolism; D004195:Disease Models, Animal; D006801:Humans; D006949:Hyperlipidemias / Q000378:metabolism; D000960:Hypolipidemic Agents; D007408:Intestinal Absorption; D008074:Lipoproteins / Q000378:metabolism*; D014018:Tissue Distribution
D001053:Apolipoproteins; D002914:Chylomicrons; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D002784:Cholesterol
Aspects biochimiques et expérimentaux de la pharmacologie des médicaments hypolipidémiants.